Roche Holding AG
šØšSwitzerland
- Country
- šØšSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 9
- Registration Number
- NCT01053663
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia
Completed
- Conditions
- Anemia
- Interventions
- Drug: methoxy polyethylene glycol-ep [Mircera]
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1580
- Registration Number
- NCT01051323
Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators
Not Applicable
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Device: Accu-Chek Combo Kit mg DE/de
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2016-03-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT01050868
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-NaĆÆve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy
Phase 3
Terminated
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 370
- Registration Number
- NCT01051011
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 118
- Registration Number
- NCT01050257
A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2016-09-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 62
- Registration Number
- NCT01046266
A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: TocilizumabDrug: Ortho-NovumĀ® 1/35
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2013-04-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 46
- Registration Number
- NCT01044498
A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 25
- Registration Number
- NCT01045083
A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes
Phase 1
Completed
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Drug: RO4998452Drug: Placebo
- First Posted Date
- 2010-01-07
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 22
- Registration Number
- NCT01044017
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 7226
- Registration Number
- NCT01042769
Ā© Copyright 2025. All Rights Reserved by MedPath